Skip to content
OpenCapital
Get started
Income StatementBalance SheetCash FlowSegments
Guardant Health logo

Guardant Health Cash Flow Statement

Operating, investing, and financing cash movements

Guardant Health generated -$187.7M in operating cash flow over the trailing twelve months. After $49.4M in capital expenditures, free cash flow was -$237.1M. Free cash flow increased 0.2% year-over-year. Based on the Q1 2026 filing.

Net Cash From Operating (TTM)-$187.7MNet Cash From Investing (TTM)$711.1MNet Cash From Financing (TTM)-$66.8MCapital Expenditures (TTM)$49.4MDepreciation And Amortization Cf (TTM)$38.9MNet Change In Cash (TTM)-$325.4M
Latest FilingQ1 2026
Report Date2026-05-07
Market Cap$17.2B
ROE200.62%

Operating

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Other non-cash income (expense)-$4.3M-$1.7M$2M$335K—$727K
Amortization of Investment Discount and Premium$4M$792K———$7M
Accretion (amortization) of discounts and premiums on investments$4M$792K———$7M
Other non-cash income (expense)-$4.3M-$1.7M$2M$335K—$727K
Change in accounts receivable$21.7M$6.1M$14.3M—$22.2M-$942K
Change in deferred revenue$9.1M$2.4M$16.7M—$4M-$3.2M
Change in inventories—$6.2M$6.8M$6.4M—-$2M
Change in other assets—$3.1M$4.2M$1.3M—$7.2M
Other working capital changes-$4.3M-$1.7M$2M$335K—$727K
Depreciation and amortization$10.5M$10.2M$10M$9.4M$10.1M$9.4M
Impairment charges$0$5M——$13.6M$0
Accretion (Amortization) of Investment Discounts and Premiums$4M$792K———$7M
Other Non-Cash Income (Expense)-$4.3M-$1.7M$2M$335K—$727K
Loss on extinguishment of debt$0$13.7M———$0
Other Non-cash Income (Expense)-$4.3M-$1.7M$2M$335K—$727K
Other Non-cash Income (Expense)-$4.3M-$1.7M$2M$335K—$727K
Net cash from operating activities-$64.5M-$62.7M-$60.3M-$35.4M-$26.4M-$65.6M
Net income-$111M-$95.2M-$99.9M-$92.7M-$128.5M-$112.1M
Other non-cash income (expense)-$4.3M-$1.7M$2M$335K—$727K
Accretion (Amortization) of Discounts and Premiums, Investments$4M$792K———$7M
Accounts payable and accrued liabilities—-$1.5M-$2.7M$3.3M$53.7M-$8.2M
Operating lease liabilities-$9.1M-$9.6M-$9.3M-$9.2M-$9.5M-$8.6M
Other legal liabilities$0$0$0$0$0—
Increase (Decrease) in Other Operating Assets$814K-$697K-$388K——-$1.1M
Increase (Decrease) in Prepaid Expense and Other Assets—$3.1M$4.2M$1.3M—$7.2M
Operating lease costs$7.8M$7.9M$8.6M$8.6M$8.6M$8.6M
Impairment of assets and other charges$0$5M——$13.6M$0
Other Noncash Income (Expense)-$4.3M-$1.7M$2M$335K—$727K
Other Non-cash Income and Expense-$4.3M-$1.7M$2M$335K—$727K
Other Non-Cash Adjustments-$4.3M-$1.7M$2M$335K—$727K
Other Non-Cash Income and Expense-$4.3M-$1.7M$2M$335K—$727K
Accretion (Amortization) of Investment Discounts and Premiums$4M$792K———$7M
Stock-based compensation$36.4M$37.8M$42.5M$42.8M$43.2M$47.6M

Financing

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Proceeds from convertible debt$0$100.6M$100.6M$100.6M$100.6M—
Proceeds from issuance of debt$0$100.6M$100.6M$100.6M$100.6M—
Payments Of Debt Issuance Costs$0$12.1M$151K$0$12.3M$102K
Other, net—-$3K-$41K$2.9M$765K-$4.5M
Payment of Deferred Purchase Consideration—-$3K-$41K$2.9M$765K-$4.5M
Noncontrolling interest transactions and other—-$3K-$41K$2.9M$765K-$4.5M
Net cash from financing activities-$2.9M-$66.9M——$732M-$21.6M
Other financing activities—-$3K-$41K$2.9M$765K-$4.5M
Payment of debt issuance costs$0$12.1M$151K$0$12.3M$102K
Noncontrolling Interests Activity and Other—-$3K-$41K$2.9M$765K-$4.5M
Proceeds from issuance of common stock$0$768K$1.6M$3.7M$327.3M$3.7M
Repurchases of common stock$0$45M———$0
Taxes paid for net share settlement$8M$15.5M$7.4M$2.3M$5.4M$20.7M
Proceeds from Hedge Financing Activities$0$5M———$0

Investing

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Capital expenditures$18.9M$4.5M$5.6M$10.4M$27.8M$5.6M
Net cash from investing activities—$302.9M——-$905.1M$699.4M
Purchases of investments$0$0——$818.2M$249.9M

Free Cash Flow

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Free cash flow-$83.4M-$67.1M-$65.9M-$45.8M-$54.2M-$71.2M

Other

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Effect of exchange rate changes on cash-$1.7M$773K$937K——-$194K
Net increase (decrease) in cash-$58.6M$174.1M——-$200.1M$612M
Proceeds From Interest Received$0$7.7M———$11.8M